16 Haziran 2021 Çarşamba

CureVac’s Covid-19 Vaccine Disappoints in Clinical Trial


By BY CARL ZIMMER from NYT Health A preliminary analysis showed that CureVac’s mRNA vaccine had an efficacy of just 47 percent. “This is pretty devastating for them,” one expert said. https://ift.tt/2TBzX7Y

Hiç yorum yok:

Yorum Gönder

Routine Childhood Vaccinations in the U.S. Slipped During the Pandemic

By BY BENJAMIN MUELLER AND JAN HOFFMAN from NYT Health Nationwide, the number of kindergartners with the required shots fell below the targ...